LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lifecore Biomedical, Inc. \De\ quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2011 to Q3 2024.
  • Lifecore Biomedical, Inc. \De\ Share-based Payment Arrangement, Expense for the quarter ending August 25, 2024 was $2.42M, a 57.8% increase year-over-year.
  • Lifecore Biomedical, Inc. \De\ Share-based Payment Arrangement, Expense for the twelve months ending August 25, 2024 was $7.09M, a 62.5% increase year-over-year.
  • Lifecore Biomedical, Inc. \De\ annual Share-based Payment Arrangement, Expense for 2023 was $6.2M, a 71.7% increase from 2022.
  • Lifecore Biomedical, Inc. \De\ annual Share-based Payment Arrangement, Expense for 2022 was $3.61M, a 38.5% increase from 2021.
  • Lifecore Biomedical, Inc. \De\ annual Share-based Payment Arrangement, Expense for 2021 was $2.61M, a 22.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.09M $2.42M +$886K +57.8% May 27, 2024 Aug 25, 2024 10-Q 2024-10-04
Q2 2024 $6.2M $1.6M +$784K +96.6% Feb 26, 2024 May 26, 2024 10-K 2024-08-26
Q1 2024 $5.42M $1.49M +$591K +65.4% Nov 27, 2023 Feb 25, 2024 10-Q 2024-08-09
Q4 2023 $4.83M $1.58M +$466K +41.9% Aug 28, 2023 Nov 26, 2023 10-Q 2024-08-09
Q3 2023 $4.36M $1.53M +$748K +95.3% May 29, 2023 Aug 27, 2023 10-Q 2024-10-04
Q2 2023 $3.61M $812K +$132K +19.4% Feb 27, 2023 May 28, 2023 10-K 2024-08-26
Q1 2023 $3.48M $903K +$281K +45.2% Nov 28, 2022 Feb 26, 2023 10-Q 2024-08-09
Q4 2022 $3.2M $1.11M +$426K +62.1% Aug 29, 2022 Nov 27, 2022 10-Q 2024-08-09
Q3 2022 $2.77M $785K +$165K +26.6% May 30, 2022 Aug 28, 2022 10-Q 2024-08-09
Q2 2022 $2.61M $680K -$99K -12.7% Feb 28, 2022 May 29, 2022 10-K 2024-08-26
Q1 2022 $2.71M $622K -$175K -22% Nov 29, 2021 Feb 27, 2022 10-Q 2023-06-02
Q4 2021 $2.88M $686K -$206K -23.1% Aug 30, 2021 Nov 28, 2021 10-Q 2023-03-16
Q3 2021 $3.09M $620K -$272K -30.5% May 31, 2021 Aug 29, 2021 10-Q/A 2023-03-16
Q2 2021 $3.36M $779K +$241K +44.8% Mar 1, 2021 May 30, 2021 10-K 2024-03-20
Q1 2021 $3.12M $797K +$231K +40.8% Nov 30, 2020 Feb 28, 2021 10-Q 2022-04-07
Q4 2020 $2.89M $892K +$105K +13.3% Aug 31, 2020 Nov 29, 2020 10-Q 2022-01-07
Q3 2020 $2.78M $892K +$364K +68.9% Jun 1, 2020 Aug 30, 2020 10-Q 2021-10-05
Q2 2020 $2.42M $538K -$540K -50.1% Feb 24, 2020 May 31, 2020 10-K/A 2023-03-16
Q1 2020 $2.96M $566K -$250K -30.6% Nov 25, 2019 Feb 23, 2020 10-Q 2021-04-08
Q4 2019 $3.21M $787K -$151K -16.1% Aug 26, 2019 Nov 24, 2019 10-Q 2021-01-07
Q3 2019 $3.36M $528K -$200K -27.5% May 27, 2019 Aug 25, 2019 10-Q 2020-10-07
Q2 2019 $3.56M $1.08M -$112K -9.41% Feb 25, 2019 May 26, 2019 10-K 2021-07-29
Q1 2019 $3.67M $816K -$331K -28.9% Nov 26, 2018 Feb 24, 2019 10-Q 2020-04-03
Q4 2018 $4M $938K -$178K -16% Aug 27, 2018 Nov 25, 2018 10-Q 2020-01-02
Q3 2018 $4.18M $728K -$222K -23.4% May 28, 2018 Aug 26, 2018 10-Q 2019-10-03
Q2 2018 $4.4M $1.19M +$68K +6.06% Feb 26, 2018 May 27, 2018 10-K 2020-08-14
Q1 2018 $4.34M $1.15M +$78K +7.3% Nov 27, 2017 Feb 25, 2018 10-Q 2019-04-04
Q4 2017 $4.26M $1.12M +$150K +15.5% Aug 28, 2017 Nov 26, 2017 10-Q 2019-01-07
Q3 2017 $4.11M $950K +$143K +17.7% May 29, 2017 Aug 27, 2017 10-Q 2018-10-05
Q2 2017 $3.96M $1.12M +$238K +26.9% Feb 27, 2017 May 28, 2017 10-K 2019-08-01
Q1 2017 $3.73M $1.07M +$185K +20.9% Nov 28, 2016 Feb 26, 2017 10-Q 2018-04-05
Q4 2016 $3.54M $966K +$66K +7.33% Aug 29, 2016 Nov 27, 2016 10-Q 2018-01-05
Q3 2016 $3.48M $807K +$10K +1.26% May 30, 2016 Aug 28, 2016 10-Q 2017-09-28
Q2 2016 $3.47M $884K +$350M Feb 29, 2016 May 29, 2016 10-K 2018-08-09
Q1 2016 -$347M $884K +$493K +126% Nov 29, 2015 Feb 28, 2016 10-Q 2017-04-07
Q4 2015 -$347M $900K -$349M -99.7% Aug 31, 2015 Nov 29, 2015 10-Q 2017-01-05
Q3 2015 $1.98M $797K +$399K +100% Jun 1, 2015 Aug 30, 2015 10-Q 2016-09-29
Q2 2015 $1.58M -$349M +$364M +51% Mar 2, 2015 May 31, 2015 10-K/A 2018-03-15
Q1 2015 -$362M $391K -$353M -99.9% Dec 1, 2014 Mar 1, 2015 10-Q 2016-03-30
Q4 2014 -$9.52M $350M -$11M -3.05% Aug 30, 2014 Nov 30, 2014 10-Q 2016-01-07
Q3 2014 $1.48M $398K +$120K +43.2% Jun 2, 2014 Aug 31, 2014 10-Q 2015-10-01
Q2 2014 $1.36M -$713M -$713M -127408% Feb 24, 2014 May 25, 2014 10-K 2016-08-01
Q1 2014 $715M $353M +$353M +75978% Nov 25, 2013 Feb 23, 2014 10-Q 2015-04-02
Q4 2013 $362M $361M +$361M +111665% Aug 26, 2013 Nov 24, 2013 10-Q 2015-01-09
Q3 2013 $1.63M $278K -$70K -20.1% May 27, 2013 Aug 25, 2013 10-Q 2014-10-08
Q2 2013 $1.7M $560K +$884M Feb 25, 2013 May 26, 2013 10-K 2015-07-31
Q1 2013 -$882M $464K +$35K +8.16% Nov 26, 2012 Feb 24, 2013 10-Q 2014-03-28
Q4 2012 -$882M $323K -$444M -99.9% Aug 27, 2012 Nov 25, 2012 10-Q 2014-01-03
Q3 2012 -$439M $348K -$441M -99.9% May 28, 2012 Aug 26, 2012 10-Q 2013-09-26
Q2 2012 $1.87M -$884M Feb 27, 2012 May 27, 2012 10-K 2014-08-01
Q1 2012 $429K Nov 28, 2011 Feb 26, 2012 10-Q 2013-04-04
Q4 2011 $444M Aug 29, 2011 Nov 27, 2011 10-Q 2013-01-04
Q3 2011 $441M May 28, 2011 Aug 28, 2011 10-Q/A 2013-01-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.